MedPath

CARBOPLATIN INJECTION BP

CARBOPLATIN INJECTION BP

Approved
DIN Number

02126680

Drug Class

Human

Market Date

Jul 30, 1997

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02126680
AIG Number0117892002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01XA02 CARBOPLATIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CARBOPLATINActive
Strength: 10 MG / ML
Monograph: CARBOPLATIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.